Protecting Women Against Human Papillomavirus: Benefits, Barriers, and Evidence-Based Strategies to Increase Vaccine Uptake

Tamera Coyne-Beasley; Bridget E Hochwalt

doi:10.18043/ncm.77.6.402

Protecting Women Against Human Papillomavirus: Benefits, Barriers, and Evidence-Based Strategies to Increase Vaccine Uptake

N C Med J. 2016 Nov-Dec;77(6):402-405. doi: 10.18043/ncm.77.6.402.

Authors

Tamera Coyne-Beasley¹, Bridget E Hochwalt²

Affiliations

¹ professor, Department of Pediatrics, Division of General Pediatrics and Adolescent Medicine, University of North Carolina at Chapel Hill; director, NC Child Health Research Network, Chapel Hill, North Carolina [email protected].
² research assistant, Department of Pediatrics, Division of General Pediatrics and Adolescent Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.

PMID: 27864489
DOI: 10.18043/ncm.77.6.402

Abstract

Human papillomavirus (HPV) infection significantly impacts women, as it can cause cancers and precancers of the cervix, vulva, vagina, oropharynx, and anus. However, many of these cancers can be prevented by HPV vaccination. Despite evidence of vaccine effectiveness and safety, vaccination rates remain low. Evidence-based strategies should be utilized to reduce barriers and increase vaccination rates.

MeSH terms

Adolescent
Adult
Child
Evidence-Based Practice / methods
Evidence-Based Practice / standards
Female
Humans
Male
Neoplasms / prevention & control*
Neoplasms / virology
Papillomavirus Infections / prevention & control*
Papillomavirus Infections / virology
Papillomavirus Vaccines / administration & dosage*
Preventive Health Services / methods
Preventive Health Services / organization & administration
Vaccination* / methods
Vaccination* / standards

Substances

Papillomavirus Vaccines